Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: FASEB J. 2020 Feb 21;34(4):5465–5482. doi: 10.1096/fj.201903287R

Figure 8. P2X4 allosteric agonist Ivermectin exacerbates ischemic AKI in mice.

Figure 8.

Wild type mice were treated with vehicle (intralipid 20%) or with ivermectin (a P2X4 allosteric agonist, 10 mg/kg 30 min before surgery) and subjected to sham-surgery or to 20 min renal ischemia and 24 hr reperfusion (IR, N=4–5). Ivermectin treatment increased renal injury measured by plasma creatinine, BUN and kidney NGAL mRNA (A), renal tubular necrosis (B and C), renal tubular apoptosis (D and E), neutrophil infiltration (F and G) and kidney cytokine mRNA induction (H). TUNEL and neutrophil immunohistochemistry show 200X magnification images. For RTPCR, fold increases in pro-inflammatory mRNAs normalized to GAPDH from quantitative RT-PCR reactions for each indicated mRNA are shown. *P < 0.05 vs. P2X4 WT sham-operated mice. #P < 0.05 vs. P2X4 WT mice subjected to renal IR injury. Error bars represent 1 SEM.